A United Kingdom supplier, with 3 awarded contracts, totalling £32.9m, most recently 12 months ago.
This public procurement contract involves the supply of medicinal products for parenteral administration containing trace elements (ATC groups B05XA31, B05XA20). These products are intended for the treatment of patients with approved indications according to the Summary of Product Characteristics (S
This public procurement contract involves the ongoing supply of medicinal products classified under ATC group N01AB08, specifically the active ingredient Sevoflurane. Additionally, it includes the delivery and installation of fully functional vaporizers that are free from defects and compatible with
This public procurement contract involves the supply of medicinal products for parenteral administration containing the active ingredient propofol at a concentration of 2% (ATC group N01AX10). These products are intended for the treatment of patients in approved indications according to the Summary
